Cambridge Isotope Laboratories (CIL) of Boston has acquired 100% of the stock of ABX Advanced Biochemical Compounds of Radeberg, Germany.
CIL, a manufacturer of stable isotope-labeled research chemicals and a supplier of O-18 water to PET nuclear pharmacies, said that the acquisition will further its efforts toward supplying nuclear medicine products for PET, SPECT, and MRI.
ABX specializes in the development and manufacturing of chemicals for nuclear medicine applications, such as PET and SPECT, and is the primary producer of GMP Mannose Triflate, an active pharmaceutical ingredient (API) for producing FDG for PET. In addition, ABX is developing GMP precursor kits for new tracers, such as F-18 fluorothymidine (FLT), and offers a wide selection of research precursors, suitable for clinical trials, for new PET compounds under development, according to CIL.
By AuntMinnie.com staff writers
September 20, 2006
Copyright © 2006 AuntMinnie.com
